Plant-based Excipients Market Size was valued at USD 1.9 billion in 2023 and is expected to reach USD 2.5 billion by 2032, growing at a CAGR of 3.0% over the forecast period 2024-2032
This report offers key statistical insights and emerging trends in the Plant-based Excipients Market within the healthcare sector. It includes the incidence and prevalence of chronic diseases for which demand is catered for, regional prescriptions for using plant drugs, and sources and volumes of application of natural excipients. The inquiry broadened the scope of healthcare expenditures, especially those expenditures borne out-of-pocket and those incurred by governments for natural pharmaceuticals. These are all geared toward giving the reader a full view of the current status, regional dynamics, and future growth potential of the market. This segment of health is on an impressive growth footing, empowered by increasing government support, demand by consumers for natural and sustainable pharmaceutical ingredients, and large-scale government initiatives.
In the United States, the plant-based excipients market has shown steady growth, increasing from USD 0.56 billion in 2023 to USD 0.73 billion by 2032 with a CAGR of 2.89%. Such growth has occurred due to increasing demand for clean-label drugs and increasing chronic diseases. Regulatory support and preference of consumers towards natural ingredients are expected to strengthen the usage of the entire market in pharmaceuticals. The plant-based excipients market is anticipated to witness steady growth on account of increased regulatory and consumer preference for natural ingredients and government R D initiatives. In 2022, the FDA initiated a pilot program intended to expedite the review process of new excipients for innovative products and thus accelerate the development of new innovations in drug formulations.
Drivers
Increased consumer inclination towards sourcing natural and clean-label pharmaceutical and nutraceutical products will strengthen demand for plant-based excipients across the globe.
Rising consumer demand towards clean and naturally derived offerings is ruling over the pharmaceutical as well as nutraceutical industry, and that has led to the growth of the plant-based excipients market. This growing health consciousness, as well as awareness concerning possible side effects of synthetic additives, is increasingly pushing both consumers and manufacturers to select plant-based alternatives in drug formulations. These excipients, derived naturally from sources such as starches, gums, cellulose, and pectins, do meet safety expectations as well as align with vegan, vegetarian, and halal-friendly product management. As regulatory bodies, health agencies advocate safer formulation practices, companies convert already existing drugs and supplements to meet this demand. It opens a huge market space for plant-derived binders, fillers, lubricants, and coating agents. The booming nutraceutical industry, which includes functional foods, dietary supplements, and herbal products, also largely depends on the use of excipients for product stability, bioavailability, and shelf life. This is a high-intensity boost towards preventive healthcare. Clean label trends are now entering into areas of prescription as well as OTC products, and manufacturers are coming up with novel approaches to add their mix of sustainable, plant-based excipients into the formulations without compromising performance. A radical change in consumer preference and consumer inclination will drive the global plant-based excipients market.
Restrain
Limited functional versatility and compatibility of plant-based excipients with certain active pharmaceutical ingredients restrict widespread adoption in innovative formulations.
Growing popularity, however, still presents significant formulation constraints for most of the plant-derived excipients in combination with selected active pharmaceutical ingredients (API). This differentiation is due to the absence of a standard molecular structure, which leads to variability in solubility, stability, and controlled-release properties concerning many plant-based excipients compared to synthetic excipients. These two points create a hurdle for pharmaceutical companies, especially concerning complex or high-potency drugs where excipient performance plays a critical performance determinant. Additionally, natural excipients are often unpredictable with APIs, affecting bioavailability or degradation in specific pH or storage conditions. These technical restrictions hinder the application of these excipients in formulations where precision and accuracy are needed, such as modified-release tablets, injectables, or biologics. It is also supply-chain dependent, as these materials are often subject to regional agricultural dependence, seasonal variations, and varied quality standards. This affects their scalability and hinders uniform batch production, which is vital for regulatory compliance.
Opportunities
Expanding applications in biologics, pediatric, and geriatric formulations are opening new avenues for plant-based excipients across the pharmaceutical industry.
There are expanding areas of application in biologics, pediatric, and geriatric formulations, which are opening up further possibilities for plant-based excipients across the pharmaceutical industry. The changing face of pharmaceutical innovation- biologics, pediatric, and geriatric medicines providing a plethora of opportunities for plant-based excipients. These formulations often request excipients that are not only biocompatible and non-toxic but also easy to metabolize and gentle on the system. Therefore, being naturally derived, plant-based excipients have a lot of positives in this area: lowered side effects and compatibility with sensitive populations. For pediatric medicines, taste-masking, digestibility, and safety considerations are the main priorities, which are best covered by some of the plant sources like pectin, guar gum, and acacia gum. The geriatric aspect focuses on easy swallowing, drug stability, and less reactivity, which reduces the potential side effects of synthetic excipients. Biologic drugs are susceptible to degradation and often require sophisticated delivery mechanisms, wherein the advantages of natural polymers enhancing stability and bioavailability apply. Furthermore, with the rise of personalized medicine and customized drug delivery systems, there emerges an opportunity for tailored plant-derived excipients. Alongside this is the continuously growing demand for compatible, safe excipients as regulatory bodies progressively approve biologics and new dosage forms. Companies supporting the research and development of innovative plant-based formulations will likely benefit from this trend. The evolving pharmaceutical ecosystem thus presents a transformative opportunity for extending the market for plant-based excipients through several drug classes and demographic areas.
Challenges
High cost of processing, purification, and quality standardization limits commercial scalability of plant-based excipients in mainstream pharmaceutical manufacturing.
A major challenge to the growth of the plant-based excipients market continues to be the high costs of processing and quality control. Synthetic excipients, which are produced in-mass through controlled chemical processes, are standard products whose production costs bear no comparison to further highly extensive extraction, purification, or refinement demanded by the stringent pharmaceutical-grade standards set out for their plant-derived counterparts. These are labor-intensive processes dependent on many variables concerning the plant source, climatic conditions, and geographic origin that invariably affect the consistency of quality. Moreover, natural ingredient sources are always susceptible to contamination through microbes, pesticides, or environmental pollutants, all of which require further decontamination and validation processes. Another major issue is to achieve uniformity across batches concerning general physicochemical properties- viscosity, solubility, and moisture content. Inherent variabilities demand more analytical testing and quality assurance in compliance with regulations such as those pronounced by the FDA or EMA. These overheads make plant-based excipients less economically attractive, especially for large-scale drug manufacturers operating under tight cost margins. Also, shelf-life and storage conditions of these natural materials may be more demanding, thereby further increasing their logistical cost. Until the standardization issues of production are resolved by technical advancement or scale economies, the commercial scalability of plant-based excipients will remain a significant industry challenge.
By Chemical Nature
In 2023, the Carbohydrates segment held dominated the plant-based excipients market with a significant revenue share of 22%. This dominance is due to some intrinsic properties of carbohydrate-based pharmaceutical excipients, such as water solubility, biodegradability, and nontoxicity, which make them highly suitable for a variety of pharmaceutical applications. They are starches, cellulosics, and gums, most of which have a wide range of applications in tablet formulation as binders, fillers, and disintegrants. Their source made them more patient-compliant and less likely to have adverse effects. The growing global trend toward natural and plant-derived ingredients in pharmaceutical formulations also aligns with carbohydrate-based excipients. Many of these excipients are classified as generally recognized as safe (GRAS) by regulatory authorities such as the U.S. FDA, facilitating their use in a broader sense. Offering favourable regulatory environments with the power of India in the pharmaceutical industry and the intrinsic superiority of carbohydrate excipients underscores their leading position in the market.
By Application and Function
In 2023, the largest share of 22% was occupied by the binders and diluents segment of the global plant-based excipients market. Binders play an essential role in pharmaceutical formulation in imparting mechanical strength to the tablets/granules and allowing the ingredients that formulate them to stick together. Such binders are obtained from plant sources, including cellulose and starch. These provide advantages of higher biodegradability, non-toxicity, and low cost. Such qualities make these plant-based binders preferable to their synthetic equivalents, especially in those formulations directed at health-conscious consumers.
Diluents, on the contrary, achieve the correct dimensions of the tablet or uniformly distribute the active pharmaceutical ingredient. Among plant-derived diluents, microcrystalline cellulose has found its way into various formulations because of its compatibility and shelf stability. Growing demand for natural excipients in over-the-counter and dietary supplement products boosts this segment's growth potential. Government support through regulatory approval has also played a pivotal role. Streamlining the approval of new excipients by the U.S. FDA only spurs manufacturers to innovate the adoption of plant-based binders and diluents further.
In 2023, the North America plant-based excipients market held the largest revenue share, 39%. This is mainly a result of some major factors such as the availability of key pharmaceutical manufacturers, advanced healthcare infrastructure, and strong regulatory frameworks that encourage the use of innovative excipients. The U.S. government's proactive approach has been complemented by FDA postings, pilot programs for excipient modernization and innovation, enabling speedier approval and commercialization of plant-based excipients. This is bolstered further by the great public appreciation for the advantages of natural and nontoxic excipients and much demand for vegan, halal, and allergen-free pharmaceutical products. Rising tendencies for chronic diseases coupled with an aging population are government health statistics, are contributing to high pharmaceutical consumption and thus a demand for high-quality excipients. North America will have an excipient market for pharmaceuticals, built on the same foundations of supply by government incentives on sustainable manufacturing and domestic production constant assured plant-based ingredients.
Asia-Pacific, on the other hand, is the fastest-growing region, projected to register the highest CAGR during the forecast period. Rapid growth has since been the product of various government initiatives, including sizable funding in healthcare infrastructure, favorable policies for pharmaceutical manufacturing, and generic drug production expansion in countries such as India and China. On one hand are the policy measures by the Chinese government in favor of the biopharma industry, while on the other is the emergence of India into the fold of a global hub for generic drugs-stepping up an increased local production of demand for plant-based excipients. Providing statistics emphasizing the patient pool within the region, rapid urbanization, and a growing middle class, all of which correlate with increased consumption of pharmaceuticals, are provided under government-specific studies for the Asia-Pacific region. The significant vegetarian and halal populations that the region boasts also contribute highly to the demand for plant-based, non-animal-derived excipients.
IFF Pharma Solutions (SeaGel Plant-based Softgel, METHOCEL Cellulose Matrix)
Roquette Frères (LYCASIN Maltitol Syrup, PEA STARCH N-735)
Ingredion Incorporated (NATIVACARE 5600, PRECISA Stabilizer System)
Ashland Global Holdings (Klucel Hydroxypropyl Cellulose, Benecel Methylcellulose)
DuPont Nutrition and Biosciences (GRINDSTED Pectin, Aquateric N100 Coating)
Colorcon Inc. (Opadry Film Coating, Nutrafinish Nutritional Coating)
DFE Pharma (Pharmatose Lactose, Starch 1500 Pregelatinized Starch)
FMC Corporation (Avicel Microcrystalline Cellulose, Ac-Di-Sol Superdisintegrant)
JRS Pharma (VIVAPUR Microcrystalline Cellulose, EMCOMPRESS Direct Compression Excipient)
MEGGLE GmbH and Co. KG (Tablettose Spray-dried Lactose, Lactose-DH Direct Compressible Lactose)
BASF SE (Kollidon Polyvinylpyrrolidone, Ludipress Co-processed Excipient)
Gattefossé (Compritol 888 ATO, Precirol ATO 5)
SPI Pharma (Pharmaburst ODT Excipient, Neusilin Magnesium Aluminometasilicate)
Kerry Group (Primex Starch Excipient, Sucralose Sweetener)
ADM (Fibersol Soluble Fiber, Soy Protein Isolate)
Cargill Incorporated (Zerose Erythritol, Satiagel Carrageenan)
Lonza Group (Capsugel Vcaps Plus, DRcaps Delayed-release Capsules)
Evonik Industries (EUDRAGIT Enteric Coating, RESOMER Biodegradable Polymer)
Croda International (Span Sorbitan Ester, Tween Polysorbate)
Lubrizol Life Science Health (Noveon AA-1, Apifil Emulsifier)
On April 19, 2023, Colorcon Inc. launched Nutracore, a range of label-friendly excipients for nutritional tablets and capsules, thus responding to the market demand for natural and sustainable ingredients.
On June 11, 2024, MEGGLE GmbH & Co. KG, at CPHI China 2024, presented its entire range of lactose-based excipients, including FlowLac and InhaLac, thus reaffirming its position in the industry for excipients.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.9 Billion |
| Market Size by 2032 | USD 2.5 Billion |
| CAGR | CAGR of 3.0% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Chemical Nature (Carbohydrates, Proteins, Polymers, Esters, Minerals, Glycoside & Waxes, Ethers & Carboxylic Acids, Others) • By Applications and Function (Binders & Diluents, Film Forming & Coating Agents, Glidants, Lubricants & Disintegrants, Plasticizers, Suspending Agents, Preservatives & Antioxidants, Colorants & Flavoring Agents) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | IFF Pharma Solutions, Roquette Frères, Ingredion Incorporated, Ashland Global Holdings, DuPont Nutrition and Biosciences, Colorcon Inc., DFE Pharma, FMC Corporation, JRS Pharma, MEGGLE GmbH and Co. KG, BASF SE, Gattefossé, SPI Pharma, Kerry Group, ADM, Cargill Incorporated, Lonza Group, Evonik Industries, Croda International, Lubrizol Life Science Health |
Ans. The projected market size for the Plant-based Excipients Market is USD 2.5 billion by 2032.
Ans: The North American region dominated the Plant-based Excipients Market in 2023.
Ans. The CAGR of the Plant-based Excipients Market is 3.0% during the forecast period of 2024-2032.
Ans: Increased consumer inclination towards sourcing natural and clean-label pharmaceutical and nutraceutical products will strengthen demand for plant-based excipients across the globe.
Ans: The Binders & Diluents segment dominated the Plant-based Excipients Market.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Prescription Trends for Plant-Based and Natural Formulations (2023), by Region
5.2 Healthcare Spending on Natural & Organic Pharmaceuticals (2023)
5.3 Regulatory Approval Trends – Clean Label and GRAS Status by Region (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Plant-based Excipients Market Segmentation, By Chemical Nature
7.1 Chapter Overview
7.2 Carbohydrates
7.2.1 Carbohydrates Market Trends Analysis (2020-2032)
7.2.2 Carbohydrates Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Proteins
7.3.1 Proteins Market Trends Analysis (2020-2032)
7.3.2 Proteins Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Polymers
7.4.1 Polymers Market Trends Analysis (2020-2032)
7.4.2 Polymers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Esters
7.5.1 Esters Market Trends Analysis (2020-2032)
7.5.2 Esters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Minerals
7.6.1 Minerals Market Trends Analysis (2020-2032)
7.6.2 Minerals Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Glycoside & Waxes
7.7.1 Glycoside & Waxes Market Trends Analysis (2020-2032)
7.7.2 Glycoside & Waxes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.8 Ethers & Carboxylic Acids
7.8.1 Ethers & Carboxylic Acids Market Trends Analysis (2020-2032)
7.8.2 Ethers & Carboxylic Acids Market Size Estimates and Forecasts to 2032 (USD Billion)
7.9 Others
7.9.1 Others Market Trends Analysis (2020-2032)
7.9.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Plant-based Excipients Market Segmentation, By Applications and Function
8.1 Chapter Overview
8.2 Binders & Diluents
8.2.1 Binders & Diluents Market Trends Analysis (2020-2032)
8.2.2 Binders & Diluents Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Film Forming & Coating Agents
8.3.1 Film Forming & Coating Agents Market Trends Analysis (2020-2032)
8.3.2 Film Forming & Coating Agents Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Glidants
8.4.1 Glidants Market Trends Analysis (2020-2032)
8.4.2 Glidants Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Lubricants & Disintegrants
8.6.1 Lubricants & Disintegrants Market Trends Analysis (2020-2032)
8.6.2 Lubricants & Disintegrants Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Plasticizers
8.7.1 Plasticizers Market Trends Analysis (2020-2032)
8.7.2 Plasticizers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.8 Suspending Agents
8.8.1 Suspending Agents Market Trends Analysis (2020-2032)
8.8.2 Suspending Agents Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Preservatives & Antioxidants
8.5.1 Preservatives & Antioxidants Market Trends Analysis (2020-2032)
8.5.2 Preservatives & Antioxidants Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Colorants & Flavoring Agents
8.5.1 Colorants & Flavoring Agents Market Trends Analysis (2020-2032)
8.5.2 Colorants & Flavoring Agents Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.2.4 North America Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.2.5.2 USA Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.2.6.2 Canada Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.2.7.2 Mexico Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.1.5.2 Poland Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.1.6.2 Romania Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.4 Western Europe Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.5.2 Germany Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.6.2 France Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.7.2 UK Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.8.2 Italy Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.9.2 Spain Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.12.2 Austria Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.4 Asia Pacific Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.5.2 China Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.5.2 India Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.5.2 Japan Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.6.2 South Korea Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.2.7.2 Vietnam Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.8.2 Singapore Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.9.2 Australia Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.1.4 Middle East Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.1.5.2 UAE Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.2.4 Africa Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Plant-based Excipients Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.6.4 Latin America Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.6.5.2 Brazil Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.6.6.2 Argentina Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.6.7.2 Colombia Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Plant-based Excipients Market Estimates and Forecasts, By Chemical Nature (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Plant-based Excipients Market Estimates and Forecasts, By Applications and Function (2020-2032) (USD Billion)
10. Company Profiles
10.1 IFF Pharma Solutions
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Roquette Frères
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Ingredion Incorporated
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Ashland Global Holdings
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 DuPont Nutrition and Biosciences
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Colorcon Inc.
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 DFE Pharma
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 FMC Corporation
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 JRS Pharma
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 MEGGLE GmbH and Co. KG
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Chemical Nature
Carbohydrates
Proteins
Polymers
Esters
Minerals
Glycoside & Waxes
Ethers & Carboxylic Acids
Others
By Applications and Function
Binders & Diluents
Film Forming & Coating Agents
Glidants
Lubricants & Disintegrants
Plasticizers
Suspending Agents
Preservatives & Antioxidants
Colorants & Flavoring Agents
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Animal Wound Care Market was valued at USD 1.32 Bn in 2023 & will reach USD 2.55 Bn by 2032 & grow at a CAGR of 7.55% from 2024 to 2032.
Burn Ointment Market Size was valued at USD 1.01 Billion in 2023 and is expected to reach USD 1.71 billion by 2032, growing at a CAGR of 6.04% over the forecast period 2024-2032.
The Medical Foam Market size was valued at USD 32.9 billion in 2023, and is expected to reach USD 54.18 billion by 2032, and grow at a CAGR of 5.7% over the forecast period 2024-2032.
The Non-alcoholic Steatohepatitis Biomarkers Market size was USD 1.14 Billion in 2023, projected to hit USD 9.1 Billion by 2032, with a 25.9% CAGR.
The immunotherapy drugs market valued at USD 246.00 billion in 2023, projected to reach USD 829.78 billion by 2032, growing at a CAGR of 14.19 %.
The Retinal Vein Occlusion Treatment Market was valued at USD 2.49 billion in 2023 and is expected to reach USD 4.35 billion by 2032, growing at a CAGR of 6.44% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
